# Antimicrobial Resistance Profiles of Bacteria Isolated from the Animal Health Sector in Zambia (2020–2024): Opportunities to Strengthen Antimicrobial Resistance Surveillance and Stewardship Programs

**Authors:** Taona Sinyawa, Fusya Goma, Chikwanda Chileshe, Ntombi B. Mudenda, Steward Mudenda, Amon Siame, Fred Mulako Simwinji, Mwendalubi Albert Hadunka, Bertha Chibwe, Kaunda Kaunda, Geoffrey Mainda, Bruno S. J. Phiri, Maisa Kasanga, Webrod Mufwambi, Samson Mukale, Andrew Bambala, Jimmy Hangoma, Nawa Mabuku, Benson Bowa, Obrian Kabunda, Mulumbi Nkamba, Ricky Chazya, Ruth Nakazwe, Mutila Malambo, Zoran Muhimba, Steven Mubamba, Morreah Champo, Mercy Mukuma, George Dautu, Chileshe Lukwesa, O-Tipo Shikanga, Freddie Masaninga, Mpela Chibi, Sandra Diana Mwadetsa, Theodora Savory, Joseph Yamweka Chizimu, John Bwalya Muma, Charles Maseka, Roma Chilengi

PMC · DOI: 10.3390/antibiotics14111102 · 2025-11-02

## TL;DR

This study examines antibiotic resistance in bacteria from Zambia's animal sector, highlighting rising resistance and the need for better surveillance and stewardship.

## Contribution

The study provides new AMR data from Zambia's animal health sector, emphasizing the need for integrated surveillance and stewardship under One Health.

## Key findings

- E. coli showed high resistance to tetracycline and ampicillin but remained susceptible to aztreonam, nitrofurantoin, and imipenem.
- Resistance to amoxicillin/clavulanic acid increased significantly over the study period.
- High levels of multidrug resistance were observed in E. coli and Klebsiella pneumoniae.

## Abstract

Background/Objectives: Antimicrobial resistance (AMR) is a major global health threat that undermines treatment in humans and animals. In Zambia, where livestock production underpins food security and livelihoods, AMR challenges are aggravated by limited surveillance, weak diagnostics, and poor regulatory enforcement, facilitating the spread of resistant pathogens across the human–animal–environment interface. This study aims to analyse AMR patterns of bacterial isolates collected from Zambia’s animal health sector between 2020 and 2024, to generate evidence that informs national AMR surveillance, supports antimicrobial stewardship (AMS) interventions, and strengthens One Health strategies to mitigate the spread of resistant pathogens. Methods: We conducted a retrospective descriptive analysis of previously collected routine laboratory data from five well-established animal health AMR surveillance sentinel sites between January 2020 and December 2024. Data were analysed by year, sample type, and antimicrobial susceptibility testing (AST) profiles using WHONET. Results: A total of 1688 samples were processed, with faecal samples accounting for 87.6%. Animal environmental samples (feed, manure, litter, abattoir/meat processing floor, wall, and equipment surface swabs) (collected from abattoirs, water, and farms) increased significantly over time (p = 0.027). Overall, Escherichia coli (E. coli) (50.4%) and Enterococcus spp. (30%) were the most frequently isolated bacteria. E. coli exhibited high resistance to tetracycline (74%) and ampicillin (72%) but remained susceptible to aztreonam (98%), nitrofurantoin (95%), and imipenem (93%). Enterococcus spp. were susceptible to penicillin (84%) and ampicillin (89%) but showed borderline resistance to vancomycin (53%) and linezolid (50%). Klebsiella spp. demonstrated resistance to ciprofloxacin (52%) and gentamicin (40%), whereas Salmonella spp. remained highly susceptible. Notably, resistance to amoxicillin/clavulanic acid rose sharply from 22.2% to 81.8% (p = 0.027). Across 1416 isolates, high levels of multidrug resistance (MDR) were observed, particularly in E. coli (48.4%) and K. pneumoniae (18.6%), with notable proportions progressing toward possible Extensively Drug-Resistant (XDR) and Pan-Drug-Resistant (PDR) states. Conclusions: The findings of this study reveal rising resistance to commonly used antibiotics in the animal health sector. Despite the lack of molecular analysis, our findings underscore the urgent need for AMS programs and integrated AMR surveillance under Zambia’s One Health strategy.

## Linked entities

- **Chemicals:** tetracycline (PubChem CID 54675776), ampicillin (PubChem CID 6249), aztreonam (PubChem CID 5742832), nitrofurantoin (PubChem CID 6604200), imipenem (PubChem CID 104838), vancomycin (PubChem CID 14969), linezolid (PubChem CID 3929), ciprofloxacin (PubChem CID 2764), gentamicin (PubChem CID 3467), amoxicillin/clavulanic acid (PubChem CID 6435924)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** multidrug (MESH:D018088)
- **Chemicals:** ciprofloxacin (MESH:D002939), ampicillin (MESH:D000667), amoxicillin/clavulanic acid (MESH:D019980), nitrofurantoin (MESH:D009582), linezolid (MESH:D000069349), vancomycin (MESH:D014640), tetracycline (MESH:D013752), gentamicin (MESH:D005839), penicillin (MESH:D010406), aztreonam (MESH:D001398), imipenem (MESH:D015378)
- **Species:** Klebsiella pneumoniae (species) [taxon 573], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649362/full.md

---
Source: https://tomesphere.com/paper/PMC12649362